ATRACURIUM BESYLATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for atracurium besylate and what is the scope of patent protection?

Atracurium besylate is the generic ingredient in four branded drugs marketed by Baxter Hlthcare, Baxter Hlthcare Corp, Eugia Pharma, Hikma, Hospira, Hospira Inc, Meitheal, Norvium Bioscience, Teva Parenteral, Watson Pharms Teva, and Watson Labs Inc, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for atracurium besylate. Three suppliers are listed for this compound.

Sponsor	Phase
Tanta University	N/A
Cairo University	Phase 4
Theodor Bilharz Research Institute	Phase 4

Sponsor

Phase

Tanta University

N/A

Cairo University

Phase 4

Theodor Bilharz Research Institute

Phase 4

US Patents and Regulatory Information for ATRACURIUM BESYLATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Parenteral	ATRACURIUM BESYLATE	atracurium besylate	INJECTABLE;INJECTION	074784-001	Jun 11, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	ATRACURIUM BESYLATE	atracurium besylate	INJECTABLE;INJECTION	206096-001	Jun 22, 2017		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	ATRACURIUM BESYLATE	atracurium besylate	INJECTABLE;INJECTION	074740-001	Mar 28, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Meitheal	ATRACURIUM BESYLATE	atracurium besylate	INJECTABLE;INJECTION	091489-001	Feb 17, 2012	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Baxter Hlthcare Corp	ATRACURIUM BESYLATE	atracurium besylate	INJECTABLE;INJECTION	074753-001	Jan 23, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hospira	TRACRIUM PRESERVATIVE FREE	atracurium besylate	INJECTABLE;INJECTION	018831-001	Nov 23, 1983	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

Hospira

TRACRIUM PRESERVATIVE FREE

atracurium besylate

INJECTABLE;INJECTION

018831-001

Nov 23, 1983

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	4
Applicants:	11
NDAs:	23
Drug Master File Entries:	16
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	101
Clinical Trials:	14
Patent Applications:	1,128
What excipients (inactive ingredients) are in ATRACURIUM BESYLATE?	ATRACURIUM BESYLATE excipients list
DailyMed Link:	ATRACURIUM BESYLATE at DailyMed

Drug Class	Nondepolarizing Neuromuscular Blocker
Physiological Effect	Neuromuscular Nondepolarizing Blockade

ATRACURIUM BESYLATE - Generic Drug Details

What are the generic sources for atracurium besylate and what is the scope of patent protection?

Summary for ATRACURIUM BESYLATE

Recent Clinical Trials for ATRACURIUM BESYLATE

Pharmacology for ATRACURIUM BESYLATE

Medical Subject Heading (MeSH) Categories for ATRACURIUM BESYLATE

Anatomical Therapeutic Chemical (ATC) Classes for ATRACURIUM BESYLATE

US Patents and Regulatory Information for ATRACURIUM BESYLATE

Expired US Patents for ATRACURIUM BESYLATE

Make Better Decisions: Try a trial or see plans & pricing